ProCE Banner Activity

DLBCL: Management of Primary Refractory and Relapsed/Refractory Disease

Slideset Download
Download these slides from a live symposium at ASH 2022 to gain more insight into the optimal management of primary refractory and relapsed/refractory DLBCL.

Released: December 12, 2022

Expiration: December 11, 2023

Share

Faculty

John N. Allan

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology & Medical Oncology
Weill Cornell Medicine
New York, New York